Brian W Toussaint

Learn More
PURPOSE To report the initial experience, clinical outcomes, and safety profile of 27 gauge pars plana vitrectomy (PPV) in eyes with posterior segment disease. DESIGN Multicenter, retrospective, interventional case series. METHODS setting: Private practice and tertiary care settings. STUDY POPULATION Eyes undergoing 27 gauge PPV for a vitreoretinal(More)
PURPOSE To report outcomes of patients who have undergone combined Trabectome and pars plana vitrectomy. METHODS Institutional Review Board-approved retrospective chart review of patients seen at the Cincinnati Eye Institute before January 2014 undergoing combined Trabectome and pars plana vitrectomy for uncontrolled glaucoma and visually significant(More)
PURPOSE To evaluate intravitreal aflibercept injection (IAI) in patients with presumed ocular histoplasmosis syndrome and choroidal neovascularization. METHODS Open-label randomized Phase I/II study of IAI in patients with presumed ocular histoplasmosis syndrome-related choroidal neovascularization. Thirty-nine eyes from 39 patients were randomized in a(More)
BACKGROUND AND OBJECTIVE To test the hypothesis that although intravitreal aflibercept (IVA) is expected to be more expensive, the extra cost of treatment would not result in additional vision gain compared with intravitreal bevacizumab (IVB) for the treatment of wet age-related macular degeneration (AMD). PATIENTS AND METHODS A retrospective chart review(More)
PURPOSE To report the outcomes of combined cataract surgery with toric intraocular lens (IOL) implantation when performed in conjunction with transconjunctival sutureless pars plana vitrectomy. DESIGN Retrospective interventional case series. PARTICIPANTS Consecutive series of 55 eyes of 51 patients from April 2007 to December of 2010. METHODS All(More)
  • 1